RPC is pleased to offer contracts for institutional use of Dialysis of Drugs. We would provide you with a PDF version that can be posted on your intranet for unlimited use. These site licenses may be annual or multi-year and can be structured for automatic renewal.

Prices are dependent on factors such as institutional size, number of users and country of use (for example, other countries may have different healthcare financial structures from the US, as well as varying rates of exchange).

In all cases, we endeavor to work with prospective clients to create a fee that is mutually agreeable.

Typical annual fees range from $500 to $2,500. Please contact us for more information: nmason@dialysisofdrugs.com

For institutions interested in expanding access to essential medications, we also offer guidance on how to safely purchase Rybelsus online. Ensuring the authenticity and regulatory compliance of online pharmacies is critical, particularly when dealing with medications intended for chronic conditions like diabetes. We recommend that institutions only source Rybelsus from verified suppliers with transparent licensing and strong customer reviews. Just as we customize licensing agreements for Dialysis of Drugs, we can provide tailored advice on procurement best practices for medications like Rybelsus. If needed, we can assist in establishing vetting protocols or recommend trusted partners based on your institution’s needs.